OM Earnings Date: Nov 4, 2026 (Estimated) — Outset Medical, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is OM's next earnings date?
Outset Medical, Inc. (OM) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.64 on revenue of $31.4M.
How did OM do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Outset Medical, Inc. posted EPS of -$0.80 versus the -$0.72 estimate, a miss of 6.7%. Revenue was $31.6M against a $29.0M estimate. The stock's 1-day post-earnings move was -5.8%.
How much does OM stock move after earnings?
OM beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 26.7% (up or down) in the day after earnings.
About Outset Medical, Inc.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.72 | -0.80 | -6.67% | $31.6M | ❌ Miss | -5.77% | -18.27% | -30.96% |
| 2026-05-07 | Q1 2026 | -0.84 | -0.83 | +1.19% | $27.9M | ✅ Beat | -21.05% | -18.59% | -7.69% |
| 2026-02-11 | Q4 2025 | -0.71 | -0.84 | -18.31% | $28.9M | ❌ Miss | -16.30% | -22.25% | -28.30% |
| 2025-11-10 | Q3 2025 | -0.77 | -0.69 | +10.39% | $29.4M | ✅ Beat | -48.47% | -59.24% | -63.55% |
| 2025-08-06 | Q2 2025 | -1.47 | -0.84 | +42.86% | $31.4M | ✅ Beat | +7.67% | +0.30% | +6.38% |
| 2024-11-06 | Q3 2024 | -6.30 | -5.85 | +7.14% | $28.7M | ✅ Beat | +25.16% | +45.16% | +93.55% |
| 2024-08-07 | Q2 2024 | -6.75 | -7.05 | -4.44% | $27.4M | ❌ Miss | -68.53% | -75.49% | -85.61% |
| 2024-05-08 | Q1 2024 | -8.25 | -8.55 | -3.64% | $28.2M | ❌ Miss | -20.82% | -13.80% | +8.96% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $53.5M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Product | 40.9% | $21.9M | -5.1% | $40.2M | $21.3M | $23.1M | $20.6M |
| Consumables Product | 23.2% | $12.4M | -12.2% | $27.3M | $14.2M | $14.2M | $12.2M |
| Service And Other Revenue | 18.2% | $9.7M | +16.7% | $16.6M | $8.5M | $8.3M | $8.9M |
| Consoles Product | 17.7% | $9.5M | +6.2% | $12.9M | $7.1M | $8.9M | $8.3M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.